Covancin

Covancin

• Highly effective against staphylococci,
  streptococci, pneumococci and anaerobes
• No cross allergenicity with the
  penicillins or cephalosporins
• Readily penetrates all body tissues
  including bone in therapeutic concentrations
• Remains active in the presence of
  bacterial enzymes, pus and necrotic tissue.

Indicated for the treatment of serious
or severe infections caused by susceptible strains of
methicillin-resistant (beta-lactam-resistant) staphylococci.

Effective in the treatment of
staphylococcal endocarditis including septicemia, bone infections,
lower respiratory tract infections, skin and skin structure
infections.

Organism MIC (mcg/ml)

• S.aureus: 0.8
• S.epidermidis: 0.39
• S.pneumoniate: 0.25
• S.viridans: 0.06
• S.faecalis: 0.2
• Str.Pyrogenes: 0.25